This study aims to further explore the underlying mechanisms of ZA resistance in breast cancer cells by investigating (i) BCRP activity and localization, (ii) changes in the NF‐κB pathway, and (iii) EMT. The gene discussed is ABCG2; the disease is breast cancer.